Form 4: Pediatrix Director Sells Shares

Sentiment:

Insider Transaction Filing


Pediatrix Medical Group Director Shirley A. Weis reported a sale of 36,028 shares of common stock on May 13, 2026, for a weighted average price of $23.75 per share.

Summary

  • Shirley A. Weis, a Director at Pediatrix Medical Group, Inc., reported a transaction involving common stock on May 13, 2026.
  • A total of 36,028 shares were sold at a weighted average price of $23.75 per share.
  • The sale was executed at prices ranging from $23.55 to $23.85.
  • Following the transaction, Weis directly beneficially owns 18,623 shares of common stock.
  • The reported securities are held indirectly through The Weis Family Trust, of which Shirley A. Weis and her husband are trustees.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative sentiment due to a director selling a substantial number of shares, which can be interpreted as a bearish signal.

Negatives

  • Director Shirley A. Weis sold a significant number of shares (36,028) of Pediatrix Medical Group common stock.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that insider selling, particularly by directors, can sometimes signal a lack of confidence in future stock performance, though it can also be for personal financial planning reasons. This transaction by a director of Pediatrix Medical Group warrants monitoring for any further insider activity or company announcements.

Stakeholder Impact

  • Shareholders may view the sale by a director negatively, potentially impacting investor confidence and share price.

Key Dates

DateDescription
05/13/2026Transaction Date for sale of common stock by Shirley A. Weis.
05/14/2026Date of signature on the Form 4 filing.

Recommendation

hold

The filing reports a sale of stock by a director, which is a negative event. However, without further context on the reasons for the sale or the company's overall financial health, a 'hold' recommendation is prudent, suggesting investors should await more information before making significant decisions.

Keywords

Pediatrix Medical Group, MD, Form 4, Insider Trading, Stock Sale, Director Transaction, Beneficial Ownership, Common Stock, Weis Family Trust

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.